Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 63VANDA PHARMS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 8586610

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1625

Delist Requested :

Patent Use Description : METHOD OF TREATING SCH...

Patent Expiration Date : 2027-11-02

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 8586610

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1625

Delist Requested :

Patent Use Description : METHOD OF TREATING SCH...

Patent Expiration Date : 2027-11-02

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 8586610

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1625

Delist Requested :

Patent Use Description : METHOD OF TREATING SCH...

Patent Expiration Date : 2027-11-02

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 8586610

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1625

Delist Requested :

Patent Use Description : METHOD OF TREATING SCH...

Patent Expiration Date : 2027-11-02

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 8586610

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1625

Delist Requested :

Patent Use Description : METHOD OF TREATING SCH...

Patent Expiration Date : 2027-11-02

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 9074256

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1674

Delist Requested :

Patent Use Description : DOSAGE MODIFICATION TO...

Patent Expiration Date : 2031-02-10

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 9072742

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1674

Delist Requested :

Patent Use Description : DOSAGE MODIFICATION TO...

Patent Expiration Date : 2031-01-16

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 9072742

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1674

Delist Requested :

Patent Use Description : DOSAGE MODIFICATION TO...

Patent Expiration Date : 2031-01-16

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 9074256

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1674

Delist Requested :

Patent Use Description : DOSAGE MODIFICATION TO...

Patent Expiration Date : 2031-02-10

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ILOPERIDONE

US Patent Number : 9072742

Drug Substance Claim :

Drug Product Claim :

Application Number : 22192

Patent Use Code : U-1674

Delist Requested :

Patent Use Description : DOSAGE MODIFICATION TO...

Patent Expiration Date : 2031-01-16

blank